Cardiff Oncology (CRDF) Total Current Liabilities (2011 - 2026)

Cardiff Oncology has reported Total Current Liabilities for 15 years, with the latest figure at $16.4 million in Q4 2025.

• Quarterly Total Current Liabilities rose 22.09% year-over-year to $16.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $16.4 million (up 22.09% YoY) and the FY2025 annual result came in at $16.4 million, up 22.09% from the prior year.
• Total Current Liabilities advanced to $16.4 million in Q4 2025 per CRDF's latest filing, from $14.7 million in the prior quarter.
• Over five years, Total Current Liabilities peaked at $16.7 million in Q2 2025 and troughed at $4.5 million in Q1 2021.
• A 5-year average of $10.0 million and a median of $9.1 million in 2023 frame the typical range for Total Current Liabilities.
• The sharpest annual moves came in 2021 and 2022: Total Current Liabilities fell 8.24% in 2021, then surged 85.22% in 2022.
• Over 5 years, Total Current Liabilities stood at $6.6 million in 2021, then increased by 19.04% to $7.8 million in 2022, then jumped by 33.71% to $10.4 million in 2023, then gained by 28.62% to $13.4 million in 2024, then grew by 22.09% to $16.4 million in 2025.
• According to Business Quant data, Total Current Liabilities over the past three periods registered $16.4 million, $14.7 million, and $16.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.